Thus, the findings of this current study improve our understanding of the molecular mechanisms underlying constitutive activation of NF-κB in bone metastasis of PCa, and provide novel insights into the development of anti-bone metastasis therapeutic strategies for PCa via silencing miR-210-3p. This evidence concerns the gene NFKB1 and posterior cortical atrophy.